At the end of the latest market close, Bionano Genomics Inc. (BNGO) was valued at $7.29. In that particular session, Stock kicked-off at the price of $7.382 while reaching the peak value of $7.48 and lowest value recorded on the day was $7.17. The stock current value is $7.02.
Recently in News on April 12, 2021, Bionano Genomics Announces Record Number of Presentations on Optical Genome Mapping and Structural Variation at the 2021 Annual Clinical Genetics Meeting of the ACMG. Sixteen talks and posters, fourteen of which are from US institutions, to be presented across all four of Bionano’s main target growth markets: prenatal, postnatal/constitutional genetics, blood cancers and solid tumor analysis. You can read further details here
Bionano Genomics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.69 on 02/16/21, with the lowest value was $3.91 for the same time period, recorded on 01/08/21.
Bionano Genomics Inc. (BNGO) full year performance was 2309.12%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -55.24% during the 52-week period from high price, and 2202.33% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.31 and $15.69.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6022710 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was 136.69%, having the revenues showcasing 45.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.10B, as it employees total of 147 workers.
Bionano Genomics Inc. (BNGO) in the eye of market guru’s
During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.48, with a change in the price was noted +6.57. In a similar fashion, Bionano Genomics Inc. posted a movement of +1,266.69% for the period of last 100 days, recording 60,981,934 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 0.46 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.46.
Bionano Genomics Inc. (BNGO): Stocks Technical analysis and Trends
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 14.89%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 5.65%. In the last 20 days, the company’s Stochastic %K was 13.10% and its Stochastic %D was recorded 17.65%.
If we look into the earlier routines of Bionano Genomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 136.69%. Additionally, trading for the stock in the period of the last six months notably improved by 1089.23%, alongside a boost of 2309.12% for the period of the last 12 months. The shares increased approximately by -6.90% in the 7-day charts and went up by -15.92% in the period of the last 30 days. Common stock shares were driven by 45.80% during last recorded quarter.